Cargando…
Evidence of poor adherence to secondary prevention after acute coronary syndromes: possible remedies through the application of new technologies
Adherence to secondary prevention medications following acute coronary syndrome (ACS) is disappointingly low, standing around 40–75% by various estimates. This is an inefficient use of the resources devoted to their development and implementation, and also puts patients at higher risk of poor outcom...
Autores principales: | Cheng, Kevin, Ingram, Nicola, Keenan, Jan, Choudhury, Robin P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329405/ https://www.ncbi.nlm.nih.gov/pubmed/25713726 http://dx.doi.org/10.1136/openhrt-2014-000166 |
Ejemplares similares
-
Interhospital and interindividual variability in secondary prevention: a comparison of outpatients with a history of chronic coronary syndrome versus outpatients with a history of acute coronary syndrome (the iASPIRE Study)
por: Curneen, James MG, et al.
Publicado: (2021) -
Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand
por: Redfern, Julie, et al.
Publicado: (2014) -
Plasma cytokines and risk of coronary heart disease in the PROCARDIS study
por: Clarke, Robert, et al.
Publicado: (2018) -
Convalescent troponin and cardiovascular death following acute coronary syndrome
por: Adamson, Philip D, et al.
Publicado: (2019) -
Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events
por: Brown, Rosemary Elisabeth, et al.
Publicado: (2020)